Breast Cancer Symposium | Evaluation Questionnaire BCS | Evaluation Questionnaire How likely are you to recommend this course to a friend or colleague? * 1 2 3 4 5 (1-Not Likely to 5-Very Likely) I attest that I have completed this educational activity in its entirety. * Yes No Were faculty disclosures made prior to the start of the CME activity? * Yes No Please rate whether the following educational objectives were met. Review the recent developments in breast surgical approaches, including upfront and after neoadjuvant chemotherapy, including the decision-making approach to axillary interrogation. * Agree Disagree Neutral Discuss the disparities encountered and identified in the breast cancer patient. * Agree Disagree Neutral Explain the rationale for reconstruction options post neoadjuvant chemotherapy and radiation therapy. * Agree Disagree Neutral Discuss updates in breast cancer imaging for earlier detection. * Agree Disagree Neutral Explore the understanding of subsets of aggressive breast pathology and molecular profiling. * Agree Disagree Neutral Identify therapeutic advances in early and advanced hormone receptor-positive, HER2 neu overexpressing, and triple-negative breast cancer. * Agree Disagree Neutral Review the advances in radiation therapy and outcomes, including short-course radiation therapy and de-escalation, and who may not need radiation therapy in breast conservation. * Agree Disagree Neutral Describe the management of HER2-positive early breast cancer in the older patient and understand the psychosocial, histologic and treatment disparities of the older breast cancer patient. * Agree Disagree Neutral Understanding genetic mutations and approach to treatment. * Agree Disagree Neutral Identify the new and emerging systemic treatment options for breast cancer brain metastases beyond surgery and radiotherapy. * Agree Disagree Neutral Understanding the science and therapeutic options using molecular profiling for patients with breast cancer. * Agree Disagree Neutral Explain the mechanism of action and rationale for immunotherapy. * Agree Disagree Neutral Discussing the psychosocial health of the oncology health provider. * Agree Disagree Neutral Updates on nutritional health for patients with early and advanced breast cancer. * Agree Disagree Neutral Bone health and when and when not to intervene. * Agree Disagree Neutral Please rate the projected impact of this activity on your knowledge, competence, performance, and patient outcomes: This activity increased my knowledge. * Yes No No Change This activity increased my competence. * Yes No No Change This activity increased my performance. * Yes No No Change This activity increased my patient outcomes. * Yes No No Change Do you feel the activity was scientifically sound and free of commercial bias or influence? Do you feel the activity was scientifically sound and free of commercial bias or influence? Yes No Comments Please identify how you will change your practice as a result of attending this activity. This activity validated my current practice. No changes will be made. * Yes No Create/revise protocols, policies, and/or procedures * Yes No Change the management and/or treatment of my patients * Yes No Other Please indicate any barriers you perceive in implementing these changes. * Cost Lack of experience Lack of opportunity (patients) Lack of resources (equipment) Lack of administrative support Lack of time to assess/counsel patients Patient compliance issues Lack of consensus or professional guidelines No barriers OtherOther Will you attempt to address these barriers in order to implement changes in your competence, performance, and/or patients' outcomes? * Yes No NA The content of this activity matched my current (or potential) scope of practice. * Yes No Please rate the following faculty - Friday, September 23rd: Anne O'Dea, MD The speaker was knowledgeable and effective; and the presentation was free of bias and scientifically rigorous * Agree Disagree Neutral NA Comments Babak Mehrara, MD The speaker was knowledgeable and effective; and the presentation was free of bias and scientifically rigorous * Agree Disagree Neutral NA Comments Beryl McCormick, MD The speaker was knowledgeable and effective; and the presentation was free of bias and scientifically rigorous * Agree Disagree Neutral NA Comments Chau Dang MD The speaker was knowledgeable and effective; and the presentation was free of bias and scientifically rigorous * Agree Disagree Neutral NA Comments Claudine Isaacs, MD The speaker was knowledgeable and effective; and the presentation was free of bias and scientifically rigorous * Agree Disagree Neutral NA Comments Edith Perez, MD The speaker was knowledgeable and effective; and the presentation was free of bias and scientifically rigorous * Agree Disagree Neutral NA Comments Eleftherios Mamounas, MD The speaker was knowledgeable and effective; and the presentation was free of bias and scientifically rigorous * Agree Disagree Neutral NA Comments Elizabeth Morris, MD The speaker was knowledgeable and effective; and the presentation was free of bias and scientifically rigorous * Agree Disagree Neutral NA Comments More Faculty Frank Arena, MD The speaker was knowledgeable and effective; and the presentation was free of bias and scientifically rigorous * Agree Disagree Neutral NA Comments Heidi Godoy, MD The speaker was knowledgeable and effective; and the presentation was free of bias and scientifically rigorous * Agree Disagree Neutral NA Comments Hyman Muss, MD The speaker was knowledgeable and effective; and the presentation was free of bias and scientifically rigorous * Agree Disagree Neutral NA Comments Jeanne Carter, MD The speaker was knowledgeable and effective; and the presentation was free of bias and scientifically rigorous * Agree Disagree Neutral NA Comments Jennifer Marti, MD The speaker was knowledgeable and effective; and the presentation was free of bias and scientifically rigorous * Agree Disagree Neutral NA Comments Jessica Wilcox, MD The speaker was knowledgeable and effective; and the presentation was free of bias and scientifically rigorous * Agree Disagree Neutral NA Comments Joyce O'Shaughnessy, MD The speaker was knowledgeable and effective; and the presentation was free of bias and scientifically rigorous * Agree Disagree Neutral NA Comments Komal Jhaveri, MD The speaker was knowledgeable and effective; and the presentation was free of bias and scientifically rigorous * Agree Disagree Neutral NA Comments Mark Robson, MD The speaker was knowledgeable and effective; and the presentation was free of bias and scientifically rigorous * Agree Disagree Neutral NA Comments More Faculty Neil Iyengar, MD The speaker was knowledgeable and effective; and the presentation was free of bias and scientifically rigorous * Agree Disagree Neutral NA Comments Quincey LaPlant, MD The speaker was knowledgeable and effective; and the presentation was free of bias and scientifically rigorous * Agree Disagree Neutral NA Comments Tiffany Traina, MD The speaker was knowledgeable and effective; and the presentation was free of bias and scientifically rigorous * Agree Disagree Neutral NA Comments Vijayakrishna Gadi, MD The speaker was knowledgeable and effective; and the presentation was free of bias and scientifically rigorous * Agree Disagree Neutral NA Comments Will Newman The speaker was knowledgeable and effective; and the presentation was free of bias and scientifically rigorous * Agree Disagree Neutral NA Comments Yasmin Hasan, MD The speaker was knowledgeable and effective; and the presentation was free of bias and scientifically rigorous * Agree Disagree Neutral NA Comments What is your overall evaluation of this CME activity? * Excellent Very Good Fair Poor Describe any presentations that did not meet your needs or expectations. Please share any suggestions for future topics. Captcha If you are human, leave this field blank. Submit Δ